Adagene Cash Conversion Cycle 2011-2026 | ADAG

Annual Cash Conversion Cycle Adagene

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	53.8	125	182	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
182	53.8	120

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Aptorum Group Limited APM	-400	$ 1.06	-0.93 %	$ 5.78 M	China
Arrowhead Pharmaceuticals ARWR	8.75	$ 64.9	-0.15 %	$ 8.68 B	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
Biogen BIIB	387	$ 187.4	0.75 %	$ 27.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
BioXcel Therapeutics BTAI	-2.28 K	$ 1.98	-1.0 %	$ 5.02 M	USA
CASI Pharmaceuticals CASI	11.9	$ 1.04	-2.34 %	$ 142 M	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Catalyst Biosciences CBIO	391	$ 10.74	-2.1 %	$ 707 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	-6.08 K	$ 27.0	-1.28 %	$ 1.74 M	USA
Cellectis S.A. CLLS	-839	$ 4.42	-1.34 %	$ 116 M	France
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Amphastar Pharmaceuticals AMPH	166	$ 27.75	0.02 %	$ 1.34 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	209	$ 11.13	-2.02 %	$ 720 M	USA
BioDelivery Sciences International BDSI	340	-	-4.8 %	$ 255 M	USA
Axon Enterprise AXON	86.2	$ 633.45	3.34 %	$ 48 B	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	174	$ 2.64	-0.75 %	$ 16.6 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
AstraZeneca PLC AZN	-58	$ 94.65	0.68 %	$ 96.9 B	Britain
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA